S

Syneos Health Inc
F:8IN

Watchlist Manager
Syneos Health Inc
F:8IN
Watchlist
Price: 40 EUR Market Closed
Market Cap: 4.1B EUR
Have any thoughts about
Syneos Health Inc?
Write Note

Intrinsic Value

The intrinsic value of one 8IN stock under the Base Case scenario is 50.45 EUR. Compared to the current market price of 40 EUR, Syneos Health Inc is Undervalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

8IN Intrinsic Value
50.45 EUR
Undervaluation 21%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Syneos Health Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for 8IN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about 8IN?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Syneos Health Inc

Provide an overview of the primary business activities
of Syneos Health Inc.

What unique competitive advantages
does Syneos Health Inc hold over its rivals?

What risks and challenges
does Syneos Health Inc face in the near future?

Summarize the latest earnings call
of Syneos Health Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Syneos Health Inc.

Provide P/S
for Syneos Health Inc.

Provide P/E
for Syneos Health Inc.

Provide P/OCF
for Syneos Health Inc.

Provide P/FCFE
for Syneos Health Inc.

Provide P/B
for Syneos Health Inc.

Provide EV/S
for Syneos Health Inc.

Provide EV/GP
for Syneos Health Inc.

Provide EV/EBITDA
for Syneos Health Inc.

Provide EV/EBIT
for Syneos Health Inc.

Provide EV/OCF
for Syneos Health Inc.

Provide EV/FCFF
for Syneos Health Inc.

Provide EV/IC
for Syneos Health Inc.

Show me price targets
for Syneos Health Inc made by professional analysts.

What are the Revenue projections
for Syneos Health Inc?

How accurate were the past Revenue estimates
for Syneos Health Inc?

What are the Net Income projections
for Syneos Health Inc?

How accurate were the past Net Income estimates
for Syneos Health Inc?

What are the EPS projections
for Syneos Health Inc?

How accurate were the past EPS estimates
for Syneos Health Inc?

What are the EBIT projections
for Syneos Health Inc?

How accurate were the past EBIT estimates
for Syneos Health Inc?

Compare the revenue forecasts
for Syneos Health Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Syneos Health Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Syneos Health Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Syneos Health Inc compared to its peers.

Compare the P/E ratios
of Syneos Health Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Syneos Health Inc with its peers.

Analyze the financial leverage
of Syneos Health Inc compared to its main competitors.

Show all profitability ratios
for Syneos Health Inc.

Provide ROE
for Syneos Health Inc.

Provide ROA
for Syneos Health Inc.

Provide ROIC
for Syneos Health Inc.

Provide ROCE
for Syneos Health Inc.

Provide Gross Margin
for Syneos Health Inc.

Provide Operating Margin
for Syneos Health Inc.

Provide Net Margin
for Syneos Health Inc.

Provide FCF Margin
for Syneos Health Inc.

Show all solvency ratios
for Syneos Health Inc.

Provide D/E Ratio
for Syneos Health Inc.

Provide D/A Ratio
for Syneos Health Inc.

Provide Interest Coverage Ratio
for Syneos Health Inc.

Provide Altman Z-Score Ratio
for Syneos Health Inc.

Provide Quick Ratio
for Syneos Health Inc.

Provide Current Ratio
for Syneos Health Inc.

Provide Cash Ratio
for Syneos Health Inc.

What is the historical Revenue growth
over the last 5 years for Syneos Health Inc?

What is the historical Net Income growth
over the last 5 years for Syneos Health Inc?

What is the current Free Cash Flow
of Syneos Health Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Syneos Health Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Syneos Health Inc

Current Assets 2B
Cash & Short-Term Investments 82.3m
Receivables 1.7B
Other Current Assets 169.9m
Non-Current Assets 6.1B
PP&E 332.6m
Intangibles 5.5B
Other Non-Current Assets 270.9m
Current Liabilities 1.6B
Accounts Payable 137m
Accrued Liabilities 657.4m
Other Current Liabilities 832.7m
Non-Current Liabilities 3B
Long-Term Debt 2.7B
Other Non-Current Liabilities 277.8m
Efficiency

Earnings Waterfall
Syneos Health Inc

Revenue
5.4B USD
Cost of Revenue
-4.2B USD
Gross Profit
1.2B USD
Operating Expenses
-856.8m USD
Operating Income
342.8m USD
Other Expenses
-271.6m USD
Net Income
71.2m USD

Free Cash Flow Analysis
Syneos Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

8IN Profitability Score
Profitability Due Diligence

Syneos Health Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
48/100
Profitability
Score

Syneos Health Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

8IN Solvency Score
Solvency Due Diligence

Syneos Health Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Low Altman Z-Score
43/100
Solvency
Score

Syneos Health Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

8IN Price Targets Summary
Syneos Health Inc

There are no price targets for 8IN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for 8IN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 8IN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Syneos Health Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

4.1B EUR

Dividend Yield

0%

Description

Syneos Health, Inc. engages in the provision of outsourced clinical development and commercialization services to biopharmaceutical companies. The company is headquartered in Morrisville, North Carolina and currently employs 26,751 full-time employees. The company went IPO on 2014-11-07. The company provides a range of clinical and commercial services to customers in the pharmaceutical, biotechnology, and healthcare industries. The company offers both stand-alone and integrated biopharmaceutical product development solutions ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products. The company operates through two business segments: Clinical Solutions and Commercial Solutions. Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The segment offers individual services including product development, project management, protocol development, investigational site recruitment, and clinical monitoring. The Commercial Solutions segment provides commercialization services, including deployment solutions, communication solutions, and consulting services.

Contact

NORTH CAROLINA
Morrisville
1030 Sync Street
+19198769300.0
www.syneoshealth.com

IPO

2014-11-07

Employees

26 751

Officers

CEO & Director
Ms. Michelle Keefe
Chief Financial Officer
Mr. Jason M. Meggs
Chief Operating Officer
Mr. Michael Lee Brooks
Gen. Counsel & Corp. Sec.
Mr. Jonathan Olefson
Advisor
Mr. Alistair Macdonald
Sr. VP of Fin. & Chief Accounting Officer
Ms. Donna Hildebrand Kralowetz
Show More
Pres of Technology & Data Solutions
Mr. Baba Shetty
Chief Scientific Officer
Dr. Judith Ng-Cashin M.D.
Chief Information & Digital Officer
Mr. Larry A. Pickett Jr.
Sr. VP of Investor Relations
Ronnie Speight
Show Less

See Also

Discover More
What is the Intrinsic Value of one 8IN stock?

The intrinsic value of one 8IN stock under the Base Case scenario is 50.45 EUR.

Is 8IN stock undervalued or overvalued?

Compared to the current market price of 40 EUR, Syneos Health Inc is Undervalued by 21%.

Back to Top